Investigation and Management of Bronchiectasis in Nontuberculous Mycobacterial Pulmonary Disease.
Clin Chest Med
; 44(4): 731-742, 2023 12.
Article
en En
| MEDLINE
| ID: mdl-37890912
ABSTRACT
Patients with nontuberculous mycobacterial (NTM) lung infection require life-long attention to their bronchiectasis, whether or not their NTM infection has been cured. The identification of the cause of bronchiectasis and/or coexisting diseases is important because it may affect therapeutic strategies. Airway clearance is the mainstay of bronchiectasis management. It can include multiple breathing techniques, devices, and mucoactive agents. The exact airway clearance regimen should be customized to each individual patient. Chronic pathogenic airway bacteria, such as Pseudomonas aeruginosa, may warrant consideration of eradication therapy and/or chronic use of maintenance inhaled antibiotics.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Bronquiectasia
/
Enfermedades Pulmonares
/
Infecciones por Mycobacterium no Tuberculosas
Límite:
Humans
Idioma:
En
Revista:
Clin Chest Med
Año:
2023
Tipo del documento:
Article